Tamara van Donge

Personalized use of ibuprofen in preterm neonates 109 6 Declarations Contributors SSZ and JVDA conceptualized the study. SSZ and AA designed the study. GJ and GF collected the data. GF established and validated the laboratory method. MR contributed to the design of the study. TVD conducted the literature search and carried out the initial population PK analysis. TVD and CS performed statistical analyses. AA contributed to the statistical interpretation. SSZ, CS, MP and JVDA provided relevant input that increased the quality of the manuscript substantially. TVD drafted the initial manuscript. Each author listed on the manuscript has seen and approved the submission of this version of the manuscript. Competing interests None declared. Funding SSZ is supported by New Investigator Fund, Hamilton Health Sciences. TVD, MP, AA, CS and JVDA are supported by the Eckenstein-Geigy foundation. Data availability statement The datasets generated during and/or analysed during the current study are available from the corresponding author (ORCID identifier: https://orcid. org/0000-0001-8385-0657) on reasonable request.